Trial · NCT00839800
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Percentage of Participants Who Had Experienced Asthma Exacerbation(s) at the End of the Study | Symbicort SMART | 16 | percentage of participants | ||
| The Percentage of Participants Who Had Experienced Asthma Exacerbation(s) at the End of the Study | Symbicort+Terbutaline As Needed | 22 | percentage of participants | ||
| Number of Asthma Exacerbations | Symbicort SMART | 259 | Asthma exacerbations | ||
| Number of Asthma Exacerbations | Symbicort+Terbutaline As Needed | 363 | Asthma exacerbations | ||
| Morning Peak Expiratory Flow (PEF) | Symbicort SMART | 331.8 | Standard Deviation 102.2 | Liter/minute (L/min) | |
| Morning Peak Expiratory Flow (PEF) | Symbicort+Terbutaline As Needed | 324.7 | Standard Deviation 101.9 | Liter/minute (L/min) | |
| Evening PEF | Symbicort SMART | 334.2 | Standard Deviation 102.6 | L/min | |
| Evening PEF | Symbicort+Terbutaline As Needed | 327.8 | Standard Deviation 103.1 | L/min | |
| Forced Expiratory Volume in One Second (FEV1) | Symbicort SMART | 2.258 | Standard Deviation 0.76 | Liter (L) | |
| Forced Expiratory Volume in One Second (FEV1) | Symbicort+Terbutaline As Needed | 2.222 | Standard Deviation 0.77 | Liter (L) | |
| Use of As-needed Medication | Symbicort SMART | 1.21 | Standard Deviation 1.39 | inhalations/day | |
| Use of As-needed Medication | Symbicort+Terbutaline As Needed | 1.46 | Standard Deviation 1.60 | inhalations/day | |
| Asthma Symptom Score | Symbicort SMART | 1.12 | Standard Deviation 1.04 | units on a scale | |
| Asthma Symptom Score | Symbicort+Terbutaline As Needed | 1.22 | Standard Deviation 1.02 | units on a scale | |
| Nights With Awakening(s) Due to Asthma Symptoms | Symbicort SMART | 15.7 | Standard Deviation 27.1 | Nights With Awakening(s) | |
| Nights With Awakening(s) Due to Asthma Symptoms | Symbicort+Terbutaline As Needed | 17.5 | Standard Deviation 27.2 | Nights With Awakening(s) | |
| The Percentage of Participants Who Had Experienced First Mild Asthma Exacerbations | Symbicort SMART | 71 | percentage of participants | ||
| The Percentage of Participants Who Had Experienced First Mild Asthma Exacerbations | Symbicort+Terbutaline As Needed | 80 | percentage of participants | ||
| Symptom-free Days (no Symptoms and no Awakenings) | Symbicort SMART | 45.5 | Standard Deviation 37.8 | symptom-free days | |
| Symptom-free Days (no Symptoms and no Awakenings) | Symbicort+Terbutaline As Needed | 41.6 | Standard Deviation 37.2 | symptom-free days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00839800/results